102 related articles for article (PubMed ID: 3648476)
1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
Balzarini J; Kang GJ; Dalal M; Herdewijn P; De Clercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Jul; 32(1):162-7. PubMed ID: 3648476
[TBL] [Abstract][Full Text] [Related]
2. 3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.
Herdewijn P; Balzarini J; De Clercq E; Pauwels R; Baba M; Broder S; Vanderhaeghe H
J Med Chem; 1987 Aug; 30(8):1270-8. PubMed ID: 3497272
[TBL] [Abstract][Full Text] [Related]
3. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
[TBL] [Abstract][Full Text] [Related]
4. Effects of 2',3'-dideoxynucleosides on mammalian cells and viruses.
Waqar MA; Evans MJ; Manly KF; Hughes RG; Huberman JA
J Cell Physiol; 1984 Nov; 121(2):402-8. PubMed ID: 6092393
[TBL] [Abstract][Full Text] [Related]
5. Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
Baba M; Pauwels R; Herdewijn P; De Clercq E; Desmyter J; Vandeputte M
Biochem Biophys Res Commun; 1987 Jan; 142(1):128-34. PubMed ID: 3028398
[TBL] [Abstract][Full Text] [Related]
6. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
[TBL] [Abstract][Full Text] [Related]
7. Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.
Balzarini J; Pauwels R; Herdewijn P; De Clercq E; Cooney DA; Kang GJ; Dalal M; Johns DG; Broder S
Biochem Biophys Res Commun; 1986 Oct; 140(2):735-42. PubMed ID: 3022729
[TBL] [Abstract][Full Text] [Related]
8. Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues.
Balzarini J; Baba M; Pauwels R; Herdewijn P; De Clerq E
Biochem Pharmacol; 1988 Jul; 37(14):2847-56. PubMed ID: 2840080
[TBL] [Abstract][Full Text] [Related]
9. Development of new potent and selective agents against HIV (human immunodeficiency virus).
Pauwels R; Schols D
Verh K Acad Geneeskd Belg; 1991; 53(6):629-55. PubMed ID: 1816706
[TBL] [Abstract][Full Text] [Related]
10. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
Hao Z; Cooney DA; Farquhar D; Perno CF; Zhang K; Masood R; Wilson Y; Hartman NR; Balzarini J; Johns DG
Mol Pharmacol; 1990 Feb; 37(2):157-63. PubMed ID: 1689452
[TBL] [Abstract][Full Text] [Related]
11. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
Balzarini J; Baba M; Pauwels R; Herdewijn P; Wood SG; Robins MJ; de Clercq E
Mol Pharmacol; 1988 Mar; 33(3):243-9. PubMed ID: 3258404
[TBL] [Abstract][Full Text] [Related]
12. 5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
Balzarini J; Van Aerschot A; Pauwels R; Baba M; Schols D; Herdewijn P; De Clercq E
Mol Pharmacol; 1989 May; 35(5):571-7. PubMed ID: 2725468
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
[TBL] [Abstract][Full Text] [Related]
14. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
15. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
De Clercq E; Balzarini J; Descamps J; Huang GF; Torrence PF; Bergstrom DE; Jones AS; Serafinowski P; Verhelst G; Walker RT
Mol Pharmacol; 1982 Jan; 21(1):217-23. PubMed ID: 7132959
[TBL] [Abstract][Full Text] [Related]
16. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 2',3'-dideoxypurine nucleosides as potential antiretroviral agents.
Kojima E; Shirasaka T; Machida M; Yoshioka H; Murakami K; Mitsuya H
Nucleic Acids Symp Ser; 1991; (25):91-2. PubMed ID: 1668777
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiester amidates of allenic nucleoside analogues: anti-HIV activity and possible mechanism of action.
Winter H; Maeda Y; Mitsuya H; Zemlicka J
J Med Chem; 1996 Aug; 39(17):3300-6. PubMed ID: 8765513
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro.
Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 Jun; 145(3):1080-6. PubMed ID: 3649230
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
